Carvedilol 3.125 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Carvedilol 3.125 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Alpha-Beta Blocker (HF Start)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Carvedilol 3.125 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Carvedilol 3.125 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Carvedilol 3.125 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Carvedilol 3.125 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Heart failure (HFrEF starting dose)
- Post-MI LV dysfunction
Mechanism of Action
Carvedilol is a non-selective beta-blocker with additional alpha-1 blockade — reduces afterload via vasodilation. One of three guideline-recommended beta-blockers for heart failure (COMET, COPERNICUS trials). Strong evidence in HFrEF.
Dosage & Administration
- Adults: 3.125 mg twice daily for 2 weeks, then double every 2 weeks to target 25 mg twice daily.
Side Effects
- Bradycardia, hypotension, dizziness, fatigue, fluid retention initially in HF.
Contraindications
- Severe bradycardia, AV block, decompensated heart failure, severe hepatic impairment, severe asthma.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Carvedilol 3.125 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 4 x 5 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Carvedilol 3.125 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Carvedilol 3.125 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Carvedilol 3.125 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Carvedilol 3.125 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Carvedilol 3.125 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Carvedilol 3.125 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Carvedilol 3.125 mg Tablet?
Available pack sizes include: 4 x 5 x 10 (Blister).
What is the MRP / trade price for Carvedilol 3.125 mg Tablet?
MRPs range from ₹1300 to ₹1300 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Carvedilol 3.125 mg Tablet?